DIAbetes Maximal ACCeleration
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 238 participants.
Also called NCT05646147
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 238 participants
- Registry
-
NCT05646147
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT05646147. Allocation not applicable; no masking; primary purpose diagnostic. Start 2023-07 (anticipated); primary completion 2025-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- DIAbetes Maximal ACCeleration
- Acronym
- DIAMACC
- Condition
- Peripheral Arterial Disease
- Condition
- Diagnosis
- Condition
- Diabetic Foot
- Intervention (Device)
- Maximal Systolic Acceleration
- Lead sponsor
- Leiden University Medical Center
Record details
- Record id
cardio:ct-nct05646147- Content hash
fd090ea13fbb59b836b43f7000a233d4cbe256ac8c83f14c92b37d4bd8c6f490